- Home
- Publications
- Publication Search
- Publication Details
Title
Trial Watch
Authors
Keywords
-
Journal
OncoImmunology
Volume 2, Issue 8, Pages e25238
Publisher
Informa UK Limited
Online
2013-09-18
DOI
10.4161/onci.25238
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway
- (2014) T. Chen et al. JOURNAL OF IMMUNOLOGY
- MicroRNAs activate natural killer cells through Toll-like receptor signaling
- (2013) S. He et al. BLOOD
- Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study
- (2013) Alexa J Resler et al. BMC CANCER
- Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors
- (2013) Nicolas Isambert et al. BMC CANCER
- Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours
- (2013) M Millward et al. BRITISH JOURNAL OF CANCER
- Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue
- (2013) J H Kauppila et al. BRITISH JOURNAL OF CANCER
- A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer
- (2013) Daniela Fenoglio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells
- (2013) Ryan M. Stephenson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of TGF-β signaling in combination with TLR7 ligation re-programs a tumoricidal phenotype in tumor-associated macrophages
- (2013) Jiao Peng et al. CANCER LETTERS
- IL-24 sensitizes tumor cells to TLR3-mediated apoptosis
- (2013) R Weiss et al. CELL DEATH AND DIFFERENTIATION
- Myeloid Differentiation Factor 88 Promotes Growth and Metastasis of Human Hepatocellular Carcinoma
- (2013) B. Liang et al. CLINICAL CANCER RESEARCH
- Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model
- (2013) Aniruddha Roy et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck
- (2013) Jean-Pascal Machiels et al. INVESTIGATIONAL NEW DRUGS
- Decoding cell death signals in liver inflammation
- (2013) Catherine Brenner et al. JOURNAL OF HEPATOLOGY
- Local Administration of TLR Ligands Rescues the Function of Tumor-Infiltrating CD8 T Cells and Enhances the Antitumor Effect of Lentivector Immunization
- (2013) H. Xiao et al. JOURNAL OF IMMUNOLOGY
- Differential Effects of Phenethyl Isothiocyanate and D,L-Sulforaphane on TLR3 Signaling
- (2013) J. Zhu et al. JOURNAL OF IMMUNOLOGY
- High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors
- (2013) Michele Sommariva et al. Journal of Translational Medicine
- The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial
- (2013) Paolo Gontero et al. JOURNAL OF UROLOGY
- Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial
- (2013) Olivier Richel et al. LANCET ONCOLOGY
- The application of Levulan®-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma
- (2013) Beata Osiecka et al. MEDICAL SCIENCE MONITOR
- Toll-Like Receptor 4 Engagement Drives Differentiation of Human and Murine Dendritic Cells from a Pro- into an Anti-Inflammatory Mode
- (2013) Romana Luger et al. PLoS One
- The Role of TLR2, TLR4 and CD14 Genetic Polymorphisms in Gastric Carcinogenesis: A Case-Control Study and Meta-Analysis
- (2013) Natalia Castaño-Rodríguez et al. PLoS One
- Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist
- (2013) L. G. Burdelya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast
- (2013) Naureen Ehsan et al. TUMOR BIOLOGY
- Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis
- (2013) Tian-Hui Zou et al. TUMOR BIOLOGY
- FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4
- (2013) Kuppusamy Balamurugan et al. Nature Communications
- Aldara activates TLR7-independent immune defence
- (2013) Anne Walter et al. Nature Communications
- Links between Toll-like receptor 4 and breast cancer
- (2013) Abubakr Ahmed et al. OncoImmunology
- Signaling via MYD88 in the pancreatic tumor microenvironment
- (2013) Constantinos P. Zambirinis et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Laurie Menger et al. OncoImmunology
- Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies
- (2012) Brenda J. Weigel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Silencing of TLR4 Increases Tumor Progression and Lung Metastasis in a Murine Model of Breast Cancer
- (2012) Abubakr Ahmed et al. ANNALS OF SURGICAL ONCOLOGY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion
- (2012) Joonas H. Kauppila et al. APMIS
- Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis
- (2012) N. Eiró et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- A Randomized Trial of the Off-label Use of Imiquimod, 5%, Cream With vs Without Tazarotene, 0.1%, Gel for the Treatment of Lentigo Maligna, Followed by Conservative Staged Excisions
- (2012) Mark A. Hyde et al. ARCHIVES OF DERMATOLOGY
- Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers
- (2012) Zhen Huang et al. BIOMATERIALS
- Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
- (2012) S. J. Dovedi et al. BLOOD
- Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation
- (2012) T. V. Brennan et al. BLOOD
- The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility
- (2012) Xie Junjie et al. BMC CANCER
- Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide
- (2012) Ying-Ying Jing et al. BMC Medicine
- Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development
- (2012) George E. Theodoropoulos et al. BREAST
- Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
- (2012) Johanna Tuomela et al. BREAST CANCER RESEARCH AND TREATMENT
- Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study
- (2012) S. van der Geer et al. BRITISH JOURNAL OF DERMATOLOGY
- HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells
- (2012) Chunhong Wang et al. CANCER BIOLOGY & THERAPY
- STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
- (2012) Hazel Tye et al. CANCER CELL
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients
- (2012) Andrés Tittarelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
- (2012) Katja Hattar et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies
- (2012) J. Karbach et al. CANCER RESEARCH
- Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells
- (2012) Ruan Min et al. CANCER SCIENCE
- Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma
- (2012) Zhi-Hui Yang et al. CANCER SCIENCE
- Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells
- (2012) Yuntao Zhang et al. CELL BIOLOGY AND TOXICOLOGY
- dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8
- (2012) Y Estornes et al. CELL DEATH AND DIFFERENTIATION
- Extracts of Larix Leptolepis effectively augments the generation of tumor antigen-specific cytotoxic T lymphocytes via activation of dendritic cells in TLR-2 and TLR-4-dependent manner
- (2012) Shin-ichi Koizumi et al. CELLULAR IMMUNOLOGY
- Reevaluating the Concept of Treating Experimental Tumors with a Mixed Bacterial Vaccine: Coley’s Toxin
- (2012) C. Maletzki et al. Clinical & Developmental Immunology
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
- (2012) S. Adams et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
- (2012) P. Sabbatini et al. CLINICAL CANCER RESEARCH
- Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
- (2012) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- The TLR4 gene polymorphisms and susceptibility to cancer: A systematic review and meta-analysis
- (2012) Kui Zhang et al. EUROPEAN JOURNAL OF CANCER
- High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy
- (2012) Yi Luo et al. EUROPEAN JOURNAL OF CANCER
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients
- (2012) Simone M. Goldinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
- (2012) Jorg Oddens et al. EUROPEAN UROLOGY
- High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
- (2012) Wei Yan et al. HEPATOLOGY
- Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure
- (2012) Pedro E. Marques et al. HEPATOLOGY
- Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice
- (2012) Heng Lin et al. HEPATOLOGY
- Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer
- (2012) Macarena Guirado et al. HUMAN IMMUNOLOGY
- Intratracheal and oral administration of SM-276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer
- (2012) Erina Koga-Yamakawa et al. INTERNATIONAL JOURNAL OF CANCER
- Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide
- (2012) Shingo Eikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer
- (2012) Xinqiang Hong et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- A 2-week Maintenance Regimen of Intravesical Instillation of Bacillus Calmette-Guerin is Safe, Adherent and Effective in Patients with Non-muscle-invasive Bladder Cancer: A Prospective, Multicenter Phase II Clinical Trial
- (2012) JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Toll-like Receptor 11 (TLR11) PreventsSalmonellaPenetration into the Murine Peyer Patches
- (2012) Zhongcheng Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Study of the Expression of Toll-Like Receptors in Different Histological Types of Colorectal Polyps and Their Relationship with Colorectal Cancer
- (2012) Noemí Eiró et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
- (2012) Atsuo Ochi et al. JOURNAL OF CLINICAL INVESTIGATION
- TLR-4 expression and decrease in chronic inflammation: indicators of aggressive follicular thyroid carcinoma
- (2012) Jaana Hagström et al. JOURNAL OF CLINICAL PATHOLOGY
- MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells
- (2012) Atsuo Ochi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Coordination between TLR9 Signaling in Macrophages and CD3 Signaling in T Cells Induces Robust Expression of IL-30
- (2012) D. Dibra et al. JOURNAL OF IMMUNOLOGY
- A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease
- (2012) X. Ding et al. JOURNAL OF IMMUNOLOGY
- Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
- (2012) Y. Shirota et al. JOURNAL OF IMMUNOLOGY
- Combination of Cyclophosphamide, Rituximab, and Intratumoral CpG Oligodeoxynucleotide Successfully Eradicates Established B cell Lymphoma
- (2012) David J. Betting et al. JOURNAL OF IMMUNOTHERAPY
- Intratumoral Delivery of Low Doses of Anti-CD40 mAb Combined With Monophosphoryl Lipid A Induces Local and Systemic Antitumor Effects in Immunocompetent and T Cell-Deficient Mice
- (2012) Tyler J. Van De Voort et al. JOURNAL OF IMMUNOTHERAPY
- Association of Toll-Like Receptor 2 Polymorphisms with Papillary Thyroid Cancer and Clinicopathologic Features in a Korean Population
- (2012) Mi Kyeong Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: Clinical and histologic outcomes
- (2012) Carlos Serra-Guillén et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients
- (2012) Valerie Chew et al. JNCI-Journal of the National Cancer Institute
- Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
- (2012) Erika Hamilton et al. Journal of Translational Medicine
- Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
- (2012) Ashish M. Kamat et al. JOURNAL OF UROLOGY
- Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer
- (2012) Johannes Falke et al. JOURNAL OF UROLOGY
- The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes
- (2012) R Bomben et al. LEUKEMIA
- Involvement of toll-like receptor 9 polymorphism in cervical cancer development
- (2012) Andrzej Roszak et al. MOLECULAR BIOLOGY REPORTS
- Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis
- (2012) Zujun Sun et al. Molecular Cancer
- An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance
- (2012) Vincenzo Cerullo et al. MOLECULAR THERAPY
- The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock
- (2012) Ezra Aksoy et al. NATURE IMMUNOLOGY
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- Ultraviolet radiation damages self noncoding RNA and is detected by TLR3
- (2012) Jamie J Bernard et al. NATURE MEDICINE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondria: master regulators of danger signalling
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Treatment of Cervical Intraepithelial Neoplasia With Topical Imiquimod
- (2012) Christoph Grimm et al. OBSTETRICS AND GYNECOLOGY
- Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
- (2012) E Lainey et al. ONCOGENE
- Polymorphism of the TLR4 Gene Reduces the Risk of Hepatitis C Virus-Induced Hepatocellular Carcinoma
- (2012) José A. Agúndez et al. ONCOLOGY
- TLR4 Signaling Promotes Immune Escape of Human Colon Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance
- (2012) Xiaoyan Tang et al. ONCOLOGY RESEARCH
- Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines
- (2012) Tomoyuki Tano et al. ORAL ONCOLOGY
- Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro
- (2012) Chih-Cheng Hsiao et al. PEDIATRIC BLOOD & CANCER
- S100A9 Interaction with TLR4 Promotes Tumor Growth
- (2012) Eva Källberg et al. PLoS One
- Mucin Depleted Foci, Colonic Preneoplastic Lesions Lacking Muc2, Show Up-Regulation of Tlr2 but Not Bacterial Infiltration
- (2012) Angelo Pietro Femia et al. PLoS One
- The Bacterial Preparation OK432 Induces IL-12p70 Secretion in Human Dendritic Cells in a TLR3 Dependent Manner
- (2012) Arnt-Ove Hovden et al. PLoS One
- An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
- (2012) Huagang Zhang et al. PLoS One
- Gene Silencing of Toll-Like Receptor 2 Inhibits Proliferation of Human Liver Cancer Cells and Secretion of Inflammatory Cytokines
- (2012) Yuzheng Huang et al. PLoS One
- Peroxiredoxin 1 Stimulates Endothelial Cell Expression of VEGF via TLR4 Dependent Activation of HIF-1α
- (2012) Jonah R. Riddell et al. PLoS One
- TLR-4 Signalling Accelerates Colon Cancer Cell Adhesion via NF-κB Mediated Transcriptional Up-Regulation of Nox-1
- (2012) D. Peter O'Leary et al. PLoS One
- MicroRNA-574-5p Was Pivotal for TLR9 Signaling Enhanced Tumor Progression via Down-Regulating Checkpoint Suppressor 1 in Human Lung Cancer
- (2012) Qinchuan Li et al. PLoS One
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
- (2012) M. Fabbri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR13 Recognizes Bacterial 23S rRNA Devoid of Erythromycin Resistance-Forming Modification
- (2012) M. Oldenburg et al. SCIENCE
- Structural Basis of TLR5-Flagellin Recognition and Signaling
- (2012) S.-i. Yoon et al. SCIENCE
- The Structure of the TLR5-Flagellin Complex: A New Mode of Pathogen Detection, Conserved Receptor Dimerization for Signaling
- (2012) J. Lu et al. Science Signaling
- Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses
- (2012) J. Garaude et al. Science Translational Medicine
- CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production
- (2012) Xiaoli Li et al. TUMOR BIOLOGY
- Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3–IRF3 signaling and type I interferons in dendritic cells
- (2012) Ce Wang et al. VACCINE
- How imiquimod licenses plasmacytoid dendritic cells to kill tumors
- (2012) Martin Holcmann et al. OncoImmunology
- Breaking the tolerance for tumor
- (2012) Theodore J. Standiford et al. OncoImmunology
- Activation of antigen-exposed iMC-DCs at the “right place” and “right time” promotes potent anti-tumor immunity
- (2012) David M. Spencer OncoImmunology
- Immune surveillance of pre-cancerous senescent hepatocytes limits hepatocellular carcinoma development
- (2012) Tetyana Yevsa et al. OncoImmunology
- Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation
- (2012) Apostolis Stathopoulos et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Targeting the right regulatory T-cell population for tumor immunotherapy
- (2012) Vivian L. Weiss et al. OncoImmunology
- Ipilimumab in a Phase II trial of melanoma patients with brain metastases
- (2012) Kim Margolin OncoImmunology
- "Flagellated" cancer cells propel anti-tumor immunity
- (2012) Johan Garaude et al. OncoImmunology
- A novel strategy for modulation of MDSC to enhance cancer immunotherapy
- (2012) Tomar Ghansah OncoImmunology
- Sound efficacy of prophylactic HPV vaccination
- (2012) Matti Lehtinen et al. OncoImmunology
- A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells
- (2012) Madhusoodhanan Rakhesh et al. OncoImmunology
- Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity
- (2012) Ravi A Madan et al. OncoImmunology
- Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progression
- (2012) Scott I. Abrams et al. OncoImmunology
- Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination
- (2012) Goodwin Jinesh G. et al. OncoImmunology
- Rage mediated DAMP signaling in intestinal tumorigenesis
- (2012) Jarom Heijmans et al. OncoImmunology
- CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
- (2012) Rebecca Waitz et al. OncoImmunology
- Effect of CpG ODN on monocytic myeloid derived suppressor cells
- (2012) Hidekazu Shirota et al. OncoImmunology
- S100A9 and tumor growth
- (2012) Tomas Leanderson et al. OncoImmunology
- Systemic cancer immunotherapy with Toll-like receptor 7 agonists
- (2012) Christian Hotz et al. OncoImmunology
- The role of innate immune signals in antitumor immunity
- (2012) Masahisa Jinushi OncoImmunology
- Modulation of DNA repair genes induced by TLR9 agonists
- (2012) Michele Sommariva et al. OncoImmunology
- Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
- (2012) Minu K. Srivastava et al. OncoImmunology
- TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b
- (2012) Dapeng Li et al. OncoImmunology
- Plasmacytoid dendritic cells and their therapeutic activity in cancer
- (2012) Aldo Pinto et al. OncoImmunology
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
- (2012) Taku Fujimura et al. OncoImmunology
- Chemoimmunomodulation of MDSCs as a novel strategy for cancer therapy
- (2012) Julie Djeu et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination
- (2012) Taylor H. Schreiber et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- Targeting PD-1/PD-L1 interactions for cancer immunotherapy
- (2012) Laurence Zitvogel et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
- (2012) Koji Kono et al. OncoImmunology
- Toll-Like Receptor 7 Agonist Therapy with Imidazoquinoline Enhances Cancer Cell Death and Increases Lymphocytic Infiltration and Proinflammatory Cytokine Production in Established Tumors of a Renal Cell Carcinoma Mouse Model
- (2012) Eric C. Kauffman et al. Journal of Oncology
- An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
- (2011) J. Stebbing et al. ANNALS OF ONCOLOGY
- In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
- (2011) Y. H. Kim et al. BLOOD
- Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
- (2011) Sheng-Jun Liao et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice
- (2011) Jon Hansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intrapleural Chemo- and Hyperthermotherapies for Malignant Pleural Effusion: A Randomized Prospective Study
- (2011) Wen-Jun Chen et al. CANCER INVESTIGATION
- Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance
- (2011) Feng-Hua Wu et al. CANCER LETTERS
- IFN Produced by TLR4-Activated Tumor Cells Is Involved in Improving the Antitumoral Immune Response
- (2011) N. G. Nunez et al. CANCER RESEARCH
- Immunotherapy with PI3K Inhibitor and Toll-Like Receptor Agonist Induces IFN- +IL-17+ Polyfunctional T Cells That Mediate Rejection of Murine Tumors
- (2011) N. A. Marshall et al. CANCER RESEARCH
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88
- (2011) Adetutu T. Egunsola et al. CELLULAR IMMUNOLOGY
- Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
- (2011) Alja Oblak et al. Clinical & Developmental Immunology
- VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
- (2011) H. Lu et al. CLINICAL CANCER RESEARCH
- The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma
- (2011) A Carvalho et al. GENES AND IMMUNITY
- A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
- (2011) Kazuhiro Kakimi et al. INTERNATIONAL JOURNAL OF CANCER
- Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice
- (2011) Mohammed Naseemuddin et al. INTERNATIONAL JOURNAL OF CANCER
- The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C
- (2011) Hans-Dieter Nischalke et al. INTERNATIONAL JOURNAL OF CANCER
- Toll-like Receptor 5 Agonist Protects Mice From Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head-and-Neck Cancer Radiotherapy
- (2011) Lyudmila G. Burdelya et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil
- (2011) Valerie Florin et al. INVESTIGATIONAL NEW DRUGS
- Randomized Trial: Immunogenicity and Safety of Coadministered Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine and Combined Hepatitis A and B Vaccine in Girls
- (2011) Court Pedersen et al. JOURNAL OF ADOLESCENT HEALTH
- TLR9 expression is associated with prognosis in patients with glioblastoma multiforme
- (2011) Lige Leng et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients
- (2011) Hisahito Endo et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma
- (2011) Rupa Narayan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mycobacterial Strains That Stimulate the Immune System Most Efficiently as Candidates for the Treatment of Bladder Cancer
- (2011) Zehra Stara Yuksel et al. JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY
- Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses
- (2011) I. Jolanda M. de Vries et al. MOLECULAR IMMUNOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Toll-like receptor 3-mediated tumor invasion in head and neck cancer
- (2011) Hui-Ching Chuang et al. ORAL ONCOLOGY
- Association of Inherited Variation in Toll-Like Receptor Genes with Malignant Melanoma Susceptibility and Survival
- (2011) Andreas Gast et al. PLoS One
- Sequence variants of toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men
- (2011) Hae Jong Kim et al. WORLD JOURNAL OF UROLOGY
- Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
- (2010) G. Schreibelt et al. BLOOD
- Circulating mitochondrial DAMPs cause inflammatory responses to injury
- (2010) Qin Zhang et al. NATURE
- The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells
- (2010) Karin Loser et al. NATURE MEDICINE
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Clinical Development of the Anti–CTLA-4 Antibody Tremelimumab
- (2010) Antoni Ribas SEMINARS IN ONCOLOGY
- Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate–gene association study
- (2009) Vassiliki Mollaki et al. JOURNAL OF HUMAN GENETICS
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
- (2008) L. G. Burdelya et al. SCIENCE
- Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
- (2008) L. Liu et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search